CURAXIS PHARMACEUTICAL CORP Operating Cash Flow
CURAXIS PHARMACEUTICAL CORP reported Operating Cash Flow of -$100.00 thousand for the 3-month period ending 2012-03-31, per its 10-Q filed 2012-05-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2012-05-14
- CURAXIS PHARMACEUTICAL CORP net cash provided by (used in) operating activities for the quarter ending 2012-03-31 was -$100.00K.
- CURAXIS PHARMACEUTICAL CORP net cash provided by (used in) operating activities for the quarter ending 2011-12-31 was -$147.00K.
- CURAXIS PHARMACEUTICAL CORP net cash provided by (used in) operating activities for the quarter ending 2011-09-30 was -$107.00K.
- CURAXIS PHARMACEUTICAL CORP net cash provided by (used in) operating activities for the quarter ending 2011-06-30 was -$104.00K.
- CURAXIS PHARMACEUTICAL CORP net cash provided by (used in) operating activities for fiscal 2011 was -$857.00K.
- CURAXIS PHARMACEUTICAL CORP net cash provided by (used in) operating activities for fiscal 2010 was -$1.32M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 41 month | Net Cash Provided by (Used in) Operating Activities 127 month | Net Cash Provided by (Used in) Operating Activities 130 month | Net Cash Provided by (Used in) Operating Activities 133 month |
|---|---|---|---|---|---|---|---|---|
| 2012-03-31 | -$100.00K 10-Q · filed 2012-05-14 | -$247.00K derived: sum of 2 quarters · filed 2012-05-14 | -$354.00K derived: sum of 3 quarters · filed 2012-05-14 | -$458.00K derived: sum of 4 quarters · filed 2012-05-14 | -$78.23M 10-Q · filed 2012-05-14 | |||
| 2011-12-31 | -$147.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-29 | -$254.00K derived: sum of 2 quarters · filed 2012-03-29 | -$358.00K derived: sum of 3 quarters · filed 2012-03-29 | -$857.00K 10-K · filed 2012-03-29 | -$78.13M 10-K · filed 2012-03-29 | |||
| 2011-09-30 | -$107.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-10 | -$211.00K derived: sum of 2 quarters · filed 2011-11-10 | -$710.00K 10-Q · filed 2011-11-10 | -$820.00K derived: sum of 4 quarters · filed 2012-05-14 | -$77.98M 10-Q · filed 2011-11-10 | |||
| 2011-06-30 | -$104.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-12 | -$603.00K 10-Q · filed 2011-08-12 | -$713.00K derived: sum of 3 quarters · filed 2012-05-14 | -$1.22M derived: sum of 4 quarters · filed 2012-05-14 | -$77.88M 10-Q · filed 2011-08-12 | |||
| 2011-03-31 | -$499.00K 10-Q · filed 2012-05-14 | -$609.00K derived: sum of 2 quarters · filed 2012-05-14 | -$1.12M derived: sum of 3 quarters · filed 2012-05-14 | |||||
| 2010-12-31 | -$110.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-29 | -$620.00K derived: sum of 2 quarters · filed 2012-03-29 | -$1.32M 10-K · filed 2012-03-29 | |||||
| 2010-09-30 | -$510.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-10 | -$1.21M 10-Q · filed 2011-11-10 | ||||||
| 2010-06-30 | -$698.00K 10-Q · filed 2011-08-12 |